The Ledger

UNH

Unitedhealth Group IncHealth Careinsider_universe

Last close $419.49Jun 28, 2026

Day −1.96%

Everything we've seen

?Jun 29, 9:55 AMdecisionconsidered
Agent 7 — Day Trader — decide: skip
UNH is down 1.74% with 350 minutes remaining — well within a full trading session, so time is not a constraining factor. The move is meaningful but sits at the lower end of the 'significant' threshold (2-5%), suggesting moderate rather than strong conviction from sellers. There are no news catalysts to anchor the move directionally, which is neutral by the guidance framework. The macro context (T10YIE at 2.1σ below trend) points to a low-rate/inflation environment that is generally supportive of defensive healthcare names like UNH, which slightly argues against continuation of the downside. However, with no news available, no reversal signals mentioned, and the system's bounded risk profile (tight -1.5% stop, +3% target), the base case is mild continuation of the established intraday trend. The macro headwind to the downside thesis keeps this from being a strong conviction call, so 0.52 reflects a marginal lean toward continuation without overweighting thin evidence.
!Jun 29, 9:55 AMsignalseverity -0.02
Agent 7 — Day Trader — day_trade_skipped
UNH is down 1.74% with 350 minutes remaining — well within a full trading session, so time is not a constraining factor. The move is meaningful but sits at the lower end of the 'significant' threshold (2-5%), suggesting moderate rather than strong conviction from sellers. There are no news catalysts to anchor the move directionally, which is neutral by the guidance framework. The macro context (T10YIE at 2.1σ below trend) points to a low-rate/inflation environment that is generally supportive of defensive healthcare names like UNH, which slightly argues against continuation of the downside. However, with no news available, no reversal signals mentioned, and the system's bounded risk profile (tight -1.5% stop, +3% target), the base case is mild continuation of the established intraday trend. The macro headwind to the downside thesis keeps this from being a strong conviction call, so 0.52 reflects a marginal lean toward continuation without overweighting thin evidence.
!Jun 29, 7:06 AMsignal
Agent 6 — Options Momentum — insufficient_capital
?Jun 26, 3:21 PMdecisionconsidered
Agent 7 — Day Trader — decide: skip
UNH is up 2.09% intraday, which represents meaningful institutional flow and should not be dismissed. However, several factors weigh against continuation into the close: (1) Only 25 minutes remain until the forced 3:45 PM ET cutoff, which severely limits the runway for further upside — even strong momentum setups compress near EOD as late-session profit-taking and position squaring dominate; (2) No supporting headlines are present to explain the move or sustain a narrative catalyst into the close; (3) The macro backdrop shows 10Y inflation breakevens 1.9σ below trend, which is mildly supportive of defensive/healthcare names on a rate-sensitivity basis, but UNH is not a pure long-duration play and this effect is weak; (4) With under 30 minutes remaining and a 2%+ move already in the books, the risk of mean-reversion or fade is elevated as participants lock in gains. The combination of very limited time remaining and no identifiable catalyst pushes the probability just below the 0.5 threshold. This is a borderline read but the time constraint is the decisive factor.
!Jun 26, 3:21 PMsignalseverity 0.02
Agent 7 — Day Trader — day_trade_skipped
UNH is up 2.09% intraday, which represents meaningful institutional flow and should not be dismissed. However, several factors weigh against continuation into the close: (1) Only 25 minutes remain until the forced 3:45 PM ET cutoff, which severely limits the runway for further upside — even strong momentum setups compress near EOD as late-session profit-taking and position squaring dominate; (2) No supporting headlines are present to explain the move or sustain a narrative catalyst into the close; (3) The macro backdrop shows 10Y inflation breakevens 1.9σ below trend, which is mildly supportive of defensive/healthcare names on a rate-sensitivity basis, but UNH is not a pure long-duration play and this effect is weak; (4) With under 30 minutes remaining and a 2%+ move already in the books, the risk of mean-reversion or fade is elevated as participants lock in gains. The combination of very limited time remaining and no identifiable catalyst pushes the probability just below the 0.5 threshold. This is a borderline read but the time constraint is the decisive factor.
!Jun 26, 12:49 PMsignal
Agent 6 — Options Momentum — insufficient_capital
!Jun 26, 11:51 AMsignal
Agent 6 — Options Momentum — insufficient_capital
!Jun 26, 10:48 AMsignal
Agent 6 — Options Momentum — insufficient_capital
!Jun 26, 10:35 AMsignal
Agent 6 — Options Momentum — insufficient_capital
!Jun 26, 10:21 AMsignal
Agent 6 — Options Momentum — insufficient_capital
!Jun 26, 9:50 AMsignal
Agent 6 — Options Momentum — insufficient_capital
?Jun 24, 10:35 AMdecisionconsidered
Agent 7 — Day Trader — decide: skip
UNH is down ~2% intraday with no attributable headline, suggesting this is either broad sector rotation or residual pressure from prior news. The macro context shows 10Y inflation breakevens 2σ below trend (T10YIE at 2.21), which is generally supportive of long-duration and defensive sectors like managed care — a mild headwind to further downside continuation. With 310 minutes remaining (essentially the full afternoon session), there is ample time for the move to continue, but the low-inflation-expectations backdrop slightly favors stabilization or mean reversion for a defensive name like UNH. No news catalyst removes a key driver of momentum persistence. The -1.98% move is meaningful but sits at the lower bound of the 2-5% 'conviction' range. Balancing the time remaining (which supports continuation opportunity) against the macro backdrop (slightly unfavorable for further selling in a defensive/healthcare name) and the absence of a catalyst, this reads as a borderline setup. Assigning 0.50 — the move may continue but there is no strong incremental evidence to push higher confidence.
!Jun 24, 10:35 AMsignalseverity -0.02
Agent 7 — Day Trader — day_trade_skipped
UNH is down ~2% intraday with no attributable headline, suggesting this is either broad sector rotation or residual pressure from prior news. The macro context shows 10Y inflation breakevens 2σ below trend (T10YIE at 2.21), which is generally supportive of long-duration and defensive sectors like managed care — a mild headwind to further downside continuation. With 310 minutes remaining (essentially the full afternoon session), there is ample time for the move to continue, but the low-inflation-expectations backdrop slightly favors stabilization or mean reversion for a defensive name like UNH. No news catalyst removes a key driver of momentum persistence. The -1.98% move is meaningful but sits at the lower bound of the 2-5% 'conviction' range. Balancing the time remaining (which supports continuation opportunity) against the macro backdrop (slightly unfavorable for further selling in a defensive/healthcare name) and the absence of a catalyst, this reads as a borderline setup. Assigning 0.50 — the move may continue but there is no strong incremental evidence to push higher confidence.
!Jun 11, 9:16 AMsignal
Agent 6 — Options Momentum — insufficient_capital
!Jun 11, 9:05 AMsignal
Agent 6 — Options Momentum — insufficient_capital
!Jun 11, 7:03 AMsignal
Agent 6 — Options Momentum — insufficient_capital
!Jun 10, 6:04 PMsignal
Agent 6 — Options Momentum — insufficient_capital
!Jun 10, 5:45 PMsignal
Agent 6 — Options Momentum — insufficient_capital
!Jun 10, 5:30 PMsignal
Agent 6 — Options Momentum — insufficient_capital
!Jun 10, 5:15 PMsignal
Agent 6 — Options Momentum — insufficient_capital
!Jun 10, 5:01 PMsignal
Agent 6 — Options Momentum — insufficient_capital
!Jun 10, 4:46 PMsignal
Agent 6 — Options Momentum — insufficient_capital
!Jun 10, 4:31 PMsignal
Agent 6 — Options Momentum — insufficient_capital
!Jun 10, 4:17 PMsignal
Agent 6 — Options Momentum — insufficient_capital
!Jun 10, 4:03 PMsignal
Agent 6 — Options Momentum — insufficient_capital
!Jun 10, 3:46 PMsignal
Agent 6 — Options Momentum — insufficient_capital
!Jun 10, 3:31 PMsignal
Agent 6 — Options Momentum — insufficient_capital
!Jun 10, 3:16 PMsignal
Agent 6 — Options Momentum — insufficient_capital
!Jun 10, 3:03 PMsignal
Agent 6 — Options Momentum — insufficient_capital
!Jun 10, 2:46 PMsignal
Agent 6 — Options Momentum — insufficient_capital
!Jun 10, 2:31 PMsignal
Agent 6 — Options Momentum — insufficient_capital
!Jun 10, 2:16 PMsignal
Agent 6 — Options Momentum — insufficient_capital
!Jun 10, 2:03 PMsignal
Agent 6 — Options Momentum — insufficient_capital
?Jun 10, 10:51 AMdecisionconsidered
Agent 7 — Day Trader — decide: skip
UNH is down 1.62% with ~295 minutes remaining — a moderate intraday decline with meaningful time left in the session. The move is below the 2-5% threshold that would indicate strong conviction flow, so it's not self-evidently high-momentum. No headlines are present to either confirm or invalidate the move, which is neutral per framework. The macro context (T10Y2Y at 2.1σ below trend, bear-flattening signal) is mildly supportive of defensives like UNH in a risk-off environment, which would ordinarily suggest support — however, the price is already moving down despite that backdrop, which is a mild bearish tell (selling into a sector that 'should' be bid). With no catalyst to drive a reversal and plenty of session time remaining, the path of least resistance is slight continuation of the downward drift. Probability set conservatively at 0.52 — modest lean toward continuation but no strong conviction signal.
?Jun 8, 3:25 PMdecisionconsidered
Agent 7 — Day Trader — decide: skip
UNH is up 1.75% with only 20 minutes until forced close. The move is moderate (not yet the 2-5% threshold of high conviction), and with just 20 minutes left there is very limited runway to reach the +3% profit target (~$12 more needed from current $406.48, implying ~$418.67 target). The macro context (T10Y2Y at 2.5σ below trend, bear-flattening environment) is modestly supportive of defensives like UNH, but this is a weak tailwind. No headlines are present to explain or sustain the move. The combination of insufficient time remaining and no catalysts to drive further momentum into the close pushes this below the 0.5 threshold — the risk/reward of capturing meaningful continuation in 20 minutes is poor given the profit target distance versus the -1.5% stop. Lean toward staying out.
?May 26, 9:00 AMdecisionconsidered
Agent 7 — Day Trader — decide: skip
UNH is up 1.57% today, a moderate move that reflects real buying interest but not an outsized surge. With 405 minutes remaining (roughly 6.75 hours — suggesting this is early-to-mid session), there is ample time for the move to extend or fade. No news headlines are available to explain the catalyst, which is common and not disqualifying per guidance. The macro context shows a flattening yield curve (T10Y2Y at 1.9σ below trend), which is mildly supportive of defensives like UNH as investors rotate toward safety. Healthcare/managed care names like UNH often exhibit sticky intraday momentum once buyers establish a trend, as institutional flows tend to accumulate rather than reverse abruptly without a news trigger. However, the move is below the 2% threshold that would signal strong conviction, and the absence of any identifiable catalyst raises the risk of a slow fade into the afternoon as the morning's momentum dissipates. On balance, the setup is a modest continuation play — supportive macro, sufficient time, real buying flow — but without a clear fundamental driver or volume confirmation signal, confidence is limited. Assigning a slight edge to continuation.
?May 18, 12:56 PMdecisionconsidered
Agent 7 — Day Trader — decide: skip
UNH is down 1.65% today, a moderate but not dramatic intraday move. There are no recent headlines to explain or amplify the move, which is a neutral factor per the guidance framework. The macro context (elevated 5Y inflation breakevens at 2.5σ above trend) is modestly negative for healthcare/managed care names like UNH, as higher inflation expectations can pressure cost structures and complicate pricing dynamics, but this is a weak secondary signal. With 170 minutes remaining there is meaningful time for the move to extend into the close. However, the move magnitude (sub-2%) is not extreme enough to strongly signal institutional conviction, and the absence of a news catalyst means this could be drift or sector rotation rather than a high-conviction directional flush. No clear reversal signals are evident either. On balance, slight lean toward continuation given time remaining and mild macro headwind, but confidence is low — this is a borderline read at the 0.5 threshold.
?May 13, 9:30 AMdecisionconsidered
Agent 7 — Day Trader — decide: skip
UNH is up 3.11% with no accompanying headlines to explain the catalyst, making it difficult to assess whether this is a sustained move or a technical bounce/short-covering rally. The macro context (elevated 5Y inflation expectations) does not directly support healthcare sector continuation. With 375 minutes remaining there is time for the move to extend, but without a clear fundamental catalyst and given UNH's recent volatility history, mean reversion or consolidation into the close is equally plausible.
?May 13, 9:15 AMdecisionconsidered
Agent 7 — Day Trader — decide: skip
UNH is up 3.11% with no accompanying headlines or identifiable catalyst, suggesting this may be a gap or technical bounce rather than a news-driven continuation move. The macro context (elevated 5-year inflation expectations) is not directly supportive of managed care/health insurance names. With 390 minutes remaining there is time for movement, but without a clear fundamental driver, mean-reversion or profit-taking into the close is a meaningful risk.
?May 13, 9:00 AMdecisionconsidered
Agent 7 — Day Trader — decide: skip
UNH is up 3.11% with no recent headlines to explain the catalyst, suggesting this may be a gap or sector rotation move rather than a news-driven continuation setup. The macro context (elevated 5-year inflation expectations at 2.5σ above trend) is more relevant to Gold, Energy, and TIPS than healthcare, providing no sector tailwind. With 405 minutes remaining there is time for the move to develop, but without a clear fundamental driver, mean reversion or consolidation is equally plausible.
?May 12, 3:15 PMdecisionconsidered
Agent 7 — Day Trader — decide: skip
UNH is up 2.75% with no recent headlines to explain the catalyst, making it difficult to assess whether this is a sustained move or a thin-volume spike. With only 30 minutes remaining until the forced close, there is limited time for meaningful additional upside even if the move is legitimate. The macro context (elevated inflation expectations) is not directly relevant to UNH, providing no additional tailwind to support continuation.
?May 12, 3:01 PMdecisionconsidered
Agent 7 — Day Trader — decide: skip
UNH is up 2.44% with no recent headlines to explain the catalyst, making it difficult to assess whether this move has fundamental support or is simply mean-reverting noise. The macro context (elevated inflation expectations via T5YIE) is not directly relevant to a managed care/health insurance name like UNH. With only 45 minutes remaining until the forced close, there is limited time for the move to extend meaningfully, and without a clear catalyst, the risk of intraday reversal or fade into the close is elevated.
?May 12, 2:45 PMdecisionconsidered
Agent 7 — Day Trader — decide: skip
UNH has moved up 3.12% with no identifiable catalyst from recent headlines, suggesting this may be a gap or thin-volume spike rather than a news-driven continuation move. The macro context (elevated inflation expectations via T5YIE) is not directly supportive of healthcare sector upside. With only 60 minutes remaining until the forced close, there is limited runway even if momentum were present, and mean-reversion risk in a no-news environment is elevated.
?May 12, 2:31 PMdecisionconsidered
Agent 7 — Day Trader — decide: skip
UNH has moved up 3.01% today but there are no supporting headlines or catalysts visible to explain the move, making it difficult to assess whether this is a fundamental re-rating or a technical/flow-driven spike. The macro context (elevated inflation expectations via T5YIE) is not directly supportive of managed care/healthcare insurers. With 74 minutes remaining, some mean reversion or consolidation is plausible absent a clear catalyst, so a high-confidence continuation call is not warranted.
?May 12, 2:15 PMdecisionconsidered
Agent 7 — Day Trader — decide: skip
UNH is up 2.15% with no recent headlines to explain the catalyst, making it difficult to assess whether this move is driven by substantive news or is a thin-volume drift. The macro context (elevated 5-year inflation expectations) is not directly relevant to managed healthcare and provides no sector tailwind. With 90 minutes remaining, there is time for continuation but without a clear catalyst, mean reversion into the close is equally plausible, especially given UNH's recent broader volatility.
?May 12, 1:30 PMdecisionconsidered
Agent 7 — Day Trader — decide: skip
UNH is up 2.61% with no identifiable news catalyst in the headlines, suggesting the move may be a gap or algorithmic/sector rotation trade rather than a fundamentally driven continuation. The macro context (elevated 5-year inflation expectations) is not a direct tailwind for managed healthcare names and provides no supporting narrative. With 135 minutes remaining there is time for continuation, but without a clear catalyst and given UNH's recent volatility history in the healthcare sector, the risk of mean reversion or fading into the close is material.
?May 12, 1:15 PMdecisionconsidered
Agent 7 — Day Trader — decide: skip
UNH is up 2.25% but there are no UNH-specific headlines or catalysts visible in the evidence to explain or support continuation of this move — the only headline references AMD and unrelated growth stocks. The macro context (elevated 5Y inflation expectations) is mildly negative for healthcare/managed care names as it pressures discount rates and cost assumptions, not a tailwind. With 150 minutes remaining there is time for a move, but without a clear fundamental catalyst driving this specific ticker, the rally looks more like a gap or sector rotation bounce that may fade rather than accelerate into the close.
❖May 11, 1:20 PMnewsvia finnhub
Advanced Micro Devices and Other Growth Stocks Are Flying High. History Says Hold on to Them.
If it feels like growth stocks can’t continue their outperformance much longer, ignore that feeling. The Vanguard S&P 500 Growth Index Fund Exchange-Traded Fund, home to companies with high sales growth including Nvidia Advanced Micro Devices Microsoft and Eli Lilly is up 13% in the past month. A couple of factors have driven the performance of the growth stocks.
❖May 11, 12:31 PMnewsvia finnhub
Optum Rx Introduces Industry’s First Transparent Pharmacy Care Model
Market-leading approach to client and consumer transparency further aligns incentives across patients and plan sponsors, offering consumers new affordability tools...
❖May 11, 10:49 AMnewsvia finnhub
Nvidia Tops Buy Point. 5 Dow Stocks Near Entries Share This Flaw
Nvidia topped a buy point on Monday after Boeing provided an entry on Friday, among five Dow stocks to watch near buy points this week. Nvidia stock and its peers have rallied in a soaring stock market, with earnings out of the way for some of these names but not for others. Walmart, Goldman Sachs and UnitedHealth also make the cut.
❖May 11, 4:34 AMnewsvia finnhub
Teva's CNS Portfolio Is Growing, But Valuation Is Stretched
Teva trades at the non-GAAP P/E ratio of 14.93x, which is 65.9% higher than Sanofi's. Find out why TEVA stock is a Sell.
❖May 11, 4:31 AMnewsvia finnhub
Dr. Scott Gottlieb: Could see more hantavirus case, but don't think it will get out of control
Former FDA Commissioner Dr. Scott Gottlieb joins 'Squawk Box' to discuss the state of the hantavirus outbreak, risk of a wider outbreak, fate of FDA Commissioner Marty Makary, FDA's new flavored vape policy, and more.
❖May 9, 8:00 AMnewsvia finnhub
Nvidia, Boeing Lead 5 Dow Stocks Near Buy Points. They Share This Flaw.
Nvidia and Boeing lead five Dow stocks to watch near buy points this week. Nvidia stock and its peers have rallied in a soaring stock market, with earnings out of the way for some of these names but not for others. Walmart, Goldman Sachs and UnitedHealth also make the cut.
❖May 9, 1:18 AMnewsvia finnhub
UnitedHealth Group (UNH) Valuation Check After Earnings Beat Guidance Lift And Prior Authorization Cuts
UnitedHealth Group (UNH) has been in focus after first quarter 2026 earnings, a higher full year earnings outlook, and plans to cut prior authorization requirements, while analysts highlighted the stock following these updates. See our latest analysis for UnitedHealth Group. The stock has reacted strongly to the first quarter earnings update and guidance lift, with a 30 day share price return of 20.15% and 90 day share price return of 33.65%. However, the 1 year total shareholder return is...
❖May 7, 7:41 PMnewsvia finnhub
UnitedHealth to Eliminate Prior Authorization for 30% of Healthcare Services
UnitedHealth Group Incorporated (NYSE:UNH) is included among the 10 Best Value Stocks to Buy in 2026 According to Warren Buffett. On May 5, UnitedHealth Group Incorporated (NYSE:UNH) announced that it is removing authorization requirements for 30% of healthcare services that previously needed insurer approval. The company said the move builds on several recent commitments aimed […]
❖May 7, 6:41 PMnewsvia finnhub
Bullish Quarterly Results: 3 Companies Raising Guidance
Guidance upgrades are generally among the most bullish announcements a company can make, signaling that the outlook is even better than previously expected.
❖May 7, 11:17 AMnewsvia finnhub
Marriott Bonvoy Business card review: Earn up to 5 free nights, worth up to 250,000 points
The Marriott Bonvoy Business card is worth keeping for its annual free night and elite status perks.
❖May 7, 10:19 AMnewsvia finnhub
How CVS Health's Transformation Is Facing A Hard Valuation Floor
The most significant insight currently obscured by CVS Health's (CVS) headline revenue growth is a high-stakes transition: the company is attempting to use a temporary surge in insurance profitability to outrun the structural margin pressures facing its pharmacy benefit management (PBM) business.
❖May 7, 4:00 AMnewsvia finnhub
UnitedHealth: Watch The Recovery In Action
UnitedHealth Group is executing a robust turnaround, with Q1 2026 revenue up 2% to $111.7 billion. Read why UNH stock is a Buy.
❖May 6, 11:46 AMnewsvia finnhub
THC Beats Q1 Earnings Estimates on Strong Ambulatory Growth, Ups '26 EPS View
Tenet Healthcare tops Q1 EPS estimates as admissions and ambulatory growth drive gains, but payer mix pressures and rising costs weigh on margins.
❖May 6, 10:09 AMnewsvia finnhub
CVS Stock Breaks Out On Earnings Due To ACA Exit, Premium Hikes
CVS stock is breaking out on Wednesday morning after it posted better-than-expected first-quarter results and raised its full-year outlook. Of CVS Health's three big segments, its health benefits segment saw operating income surge by $1.05 billion, or 53%.
❖May 6, 7:48 AMnewsvia finnhub
5 Goldman Sachs Top Picks for May Are Safe, Pay Dividends With Double-Digit Upside
Founded in 1869, Goldman Sachs is the world’s second-largest investment bank by revenue and is ranked 82nd on the Fortune 500 list of the largest U.S. corporations by total revenue. The Wall Street white-glove firm offers financing, advisory services, risk distribution, and hedging for the firm’s institutional and corporate clients. In addition, they produce some ... 5 Goldman Sachs Top Picks for May Are Safe, Pay Dividends With Double-Digit Upside
❖May 6, 7:02 AMnewsvia finnhub
CVS Health Stock Jumps After Earnings. What’s Encouraging Wall Street.
CVS Health’s Aetna was the third-largest provider of Medicare Advantage plans in 2025, behind UnitedHealth Group and Humana.
❖May 6, 3:38 AMnewsvia finnhub
Live Nation Entertainment, TransDigm Group, Interactive Brokers And A Health Care Stock: CNBC's 'Final Trades'
Live Nation and TransDigm each reported positive first-quarter earnings, while Interactive Brokers Group hit an all-time high.
❖May 5, 9:08 PMnewsvia finnhub
UnitedHealth Prior Authorization Shift And What It Could Mean For UNH Stock
UnitedHealthcare, part of UnitedHealth Group (NYSE:UNH), plans to remove prior authorization requirements for a large share of healthcare services starting in 2026. The change is intended to cut administrative complexity, while aiming to improve access and affordability for patients and providers. This policy update affects core insurance operations and could influence how hospitals, physicians and patients interact with NYSE:UNH plans. For a company of UnitedHealth Group's scale in US...
❖May 5, 6:42 PMnewsvia finnhub
Why UnitedHealth Group Stock Came Roaring Back In April
The insurer and healthcare giant is getting back to a solid profit footing.
❖May 5, 5:15 PMnewsvia finnhub
CVS Has Two Hurdles to Clear in Earnings. Medicare Advantage Just Might Be the Lower One.
CVS Health’s Aetna was the third-largest provider of Medicare Advantage plans in 2025, behind UnitedHealth Group and Humana.
❖May 5, 2:57 PMnewsvia finnhub
ENSG Tops Q1 EPS Estimates on Patient Growth, Raises '26 Outlook
Ensign Group tops Q1 EPS estimates as occupancy gains and acquisitions fuel growth, while higher costs and a slight revenue miss temper results.
❖May 5, 1:00 PMnewsvia finnhub
Highmark Health Appoints Heather Cianfrocco as Chief Operating Officer
Highmark Health announced today the appointment of Heather Cianfrocco to the role of chief operating officer for the organization, effective immediately. Cianfrocco joins Highmark Health from UnitedHealth Group where she held various leadership roles across the benefits and services businesses.
❖May 5, 12:31 PMnewsvia finnhub
Highmark Health names ex-UnitedHealth exec as COO
Heather Cianfrocco is joining the Pittsburgh-based healthcare company as its COO effective immediately.
❖May 5, 11:05 AMnewsvia finnhub
Apple, Amazon, TSMC Top List Of Earnings Triple Plays As Beat-And-Raise Stocks Surge
Apple, Amazon and TSMC are among the largest companies to deliver earnings "triple plays" this season.
❖May 5, 10:11 AMnewsvia finnhub
Goldman Sachs Names UnitedHealth (UNH) to Conviction List, Keeps $435 Price Target
UnitedHealth Group Incorporated (NYSE:UNH) is included among the 10 Best Blue Chip Stocks to Invest in According to Billionaires. On May 1, Goldman Sachs added UnitedHealth Group Incorporated (NYSE:UNH) to its U.S. Conviction List as part of its monthly update. The firm believes the company is nearing the bottom of its underwriting cycle for Medicare […]
❖May 5, 9:05 AMnewsvia finnhub
Final Trades: Live Nation, Transdigm, UnitedHealth and Interactive Brokers
The Investment Committee give you their top stocks to watch for the second half.
❖May 5, 8:40 AMnewsvia finnhub
Wall Street Lunch: Global Borrowing Costs Surge On Rising Oil, Renewed Inflation Concerns
Global borrowing costs continue to climb as elevated oil prices fuel expectations that central banks may need to tighten policy to contain renewed inflation pressures.
❖May 5, 6:00 AMnewsvia finnhub
UnitedHealthcare Cuts Prior Authorization Requirements by 30%
May 05, 2026--UnitedHealthcare is eliminating authorization requirements for 30% of healthcare services that previously required insurer approval.
❖May 5, 4:07 AMnewsvia finnhub
Iran tensions, Palantir earnings, Musk's SEC settlement and more in Morning Squawk
Here are five key things investors need to know to start the trading day.
❖May 5, 3:44 AMnewsvia finnhub
Airlines could be at a 'wild coyote moment' says analyst
Alexander Irving, Airlines Analyst at Bernstein discusses the potentially crisis in jet fuel supplies if the Iran War continues.
❖May 5, 3:00 AMnewsvia finnhub
Major health insurers show signs of recovery – but a key test looms
Insurers have incomplete data on medical costs in the first quarter due to a lag in claims processing, which sets up the second quarter as the real test.
❖May 5, 2:42 AMnewsvia finnhub
UnitedHealthcare removes prior approval requirements for 30% of healthcare services
UnitedHealth will eliminateprior approval requirements for 30% of healthcare services, itsinsurance unit said on Tuesday, further reducing delays andpaperwork for patients and doctors. ...
❖May 5, 2:08 AMnewsvia finnhub
Unitedhealthcare Is Eliminating Authorization Requirements For 30% Of Healthcare Services That Previously Required Insurer Approval
This initiative builds on a series of recent, industry-leading commitments the company has made to make healthcare simpler and more affordable, while raising the bar for transparency and accountability across the
❖May 4, 9:12 PMnewsvia finnhub
How Investors Are Reacting To UnitedHealth Group (UNH) Earnings Beat, Guidance Hike and Governance Challenge
In April 2026, UnitedHealth Group reported first-quarter 2026 results showing revenue of US$111.72 billion and net income of US$6.28 billion, while also facing a shareholder proposal from The Accountability Board to require an independent Board Chair, which the company’s proxy statement urged investors to vote against. This mix of steady financial performance and a governance challenge highlights how UnitedHealth’s board structure and oversight practices are coming under closer investor...
❖May 4, 12:52 PMnewsvia finnhub
Acadia Healthcare Q1 Earnings Beat Estimates on Rising Patient Days
ACHC Q1 tops estimates with 37 cents EPS and 7.6% revenue growth, driven by higher patient days and admissions despite shorter stays and rising costs.
❖May 4, 12:39 PMnewsvia finnhub
Select Medical Q1 Earnings Miss Estimates on Higher Expenses
SEM's Q1 EPS misses due to higher expenses and weaker patient days, even as revenues top estimates and rehab segment growth partly offsets pressure.
❖May 4, 9:40 AMnewsvia finnhub
TDOC Q1 Earnings Miss, Revenues Down Y/Y on BetterHelp Weakness
Teladoc Health posts a y/y narrower Q1 loss and beats revenue estimates as international growth and cost cuts offset BetterHelp weakness and subscription declines.
❖May 4, 8:54 AMnewsvia finnhub
Beat the Market Like Zacks: Vicor, NVIDIA, UnitedHealth in Focus
VICR, NVDA and UNH lead gains as Zacks-backed picks outperform the broader market across multiple portfolios.
❖May 4, 8:16 AMnewsvia finnhub
Here's How Much $100 Invested In UnitedHealth Group 15 Years Ago Would Be Worth Today
❖May 4, 7:43 AMnewsvia finnhub
How to buy a major Dow component, at a discount
UnitedHealth is one of the largest U.S. companies in one of the largest sectors that pays a respectable dividend. Mike Khouw still wouldn't buy the stock outright.
❖May 4, 7:42 AMnewsvia finnhub
This healthcare stock has turned a corner. Here's how to get long at a discount
Mike Khouw, strategist at YieldMaxETFs, explains why he favors an options strategy for this healthcare giant.
❖May 3, 11:13 PMnewsvia finnhub
Tracking AMG's Yacktman Asset Management Portfolio - Q1 2026 Update
Yacktman Asset Management's Q1 2026 13F portfolio rose to ~$7.5B, with 76 holdings and 11.5% cash, led by Canadian Natural Resources at 10.75%. View the full analysis here.
❖May 3, 12:36 AMnewsvia finnhub
1 Cash-Producing Stock Worth Investigating and 2 Facing Headwinds
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.
❖May 2, 8:09 AMnewsvia finnhub
Is It Time To Reassess UnitedHealth Group (UNH) After Its Sharp 30 Day Rally?
This article examines whether UnitedHealth Group at around US$368.78 may be attractively priced or simply fairly valued, and explains what the current share price could mean for you. The stock has returned 3.9% over the last 7 days and 34.6% over the last 30 days, while the 1 year return is a 5.2% decline and the 3 year return is a 20.9% decline, with a 9.6% year to date gain. Recent coverage has focused on UnitedHealth Group's role as a major US healthcare and insurance provider, including...
❖May 1, 11:49 PMnewsvia finnhub
Elon Musk's $4.8 Million Security Tab Reveals Rising Risks For Billionaire CEOs
Tesla increased security spending for CEO Elon Musk to $4.8 million in 2025, reflecting rising executive safety concerns.
❖May 1, 12:37 PMnewsvia finnhub
Goldman Sachs Adds UnitedHealth to Its Conviction List: Is the Managed Care Comeback Real?
Goldman Sachs (NYSE:GS) added UnitedHealth Group (NYSE:UNH) stock to its U.S. Conviction List, reiterating a Buy rating with a $435 price target. The firm argues UnitedHealth is nearing the bottom of its underwriting cycle in Medicare Advantage (MA), which represents 40% of its business. The Conviction List is reserved for Goldman’s highest-conviction Buy ideas. UnitedHealth ... Goldman Sachs Adds UnitedHealth to Its Conviction List: Is the Managed Care Comeback Real?
❖May 1, 12:29 PMnewsvia finnhub
UnitedHealth Stock Just Made Goldman’s Conviction List. It’s a ‘Shrink to Grow’ Story.
UnitedHealth Group’s comeback got a serious boost when it scored an earnings beat a couple of weeks ago. Now, it’s being added to Goldman Sachs’ U.S. Conviction List—Director’s Cut, an acclaimed rundown of Buy-rated stocks. Goldman likes the healthcare company’s plans to get smaller in Medicare Advantage, calling it a “shrink to grow” story.
❖May 1, 12:07 PMnewsvia finnhub
S&P 500's Best‑Kept Secret: Why Healthcare Could Be 2026's Breakout Winner
AI‑powered drug discovery, strong earnings upgrades, and rising institutional flows show why healthcare may shift from 2026 laggard to breakout S&P 500 growth story.
❖May 1, 11:32 AMnewsvia finnhub
SCHD: Go Back To Bed, Why You'll Sleep Well At Night
❖May 1, 10:27 AMnewsvia finnhub
UnitedHealth Pops 14.5% After Q1 Beat: Still a Buy or Too Late Now?
UNH surges 14.5% after a Q1 earnings beat and raised 2026 outlook, but membership declines, DOJ probes and valuation concerns could cap the rally.

← Back to dashboard